Business Description
Bionano Genomics Inc
NAICS : 334516
SIC : 3841
Share Class Description:
BNGOW: Warrants (21/08/2023)Total Employee Number:
97Description
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.85 | |||||
Equity-to-Asset | 0.58 | |||||
Debt-to-Equity | 0.45 | |||||
Debt-to-EBITDA | -0.82 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -16.21 | |||||
Beneish M-Score | -3.92 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -55.1 | |||||
3-Year EBITDA Growth Rate | 77.1 | |||||
3-Year EPS without NRI Growth Rate | 74 | |||||
3-Year FCF Growth Rate | 77.6 | |||||
3-Year Book Growth Rate | -79.8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 53.08 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 25.34 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.84 | |||||
Quick Ratio | 1.59 | |||||
Cash Ratio | 0.68 | |||||
Days Inventory | 172.44 | |||||
Days Sales Outstanding | 52.6 | |||||
Days Payable | 141.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -178.9 | |||||
Shareholder Yield % | -113.27 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 46.97 | |||||
Operating Margin % | -114.03 | |||||
Net Margin % | -109.95 | |||||
EBITDA Margin % | -72.34 | |||||
ROE % | -70.14 | |||||
ROA % | -42.48 | |||||
ROIC % | -66.62 | |||||
3-Year ROIIC % | -75.15 | |||||
ROC (Joel Greenblatt) % | -86.61 | |||||
ROCE % | -59.8 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.24 | |||||
PB Ratio | 0.34 | |||||
EV-to-EBIT | -0.52 | |||||
EV-to-EBITDA | -0.75 | |||||
EV-to-Revenue | 0.55 | |||||
EV-to-FCF | -0.81 | |||||
Earnings Yield (Greenblatt) % | -192.31 | |||||
FCF Yield % | -147.5 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BNGOW
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bionano Genomics Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | - | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0 - 4.47 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bionano Genomics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bionano Genomics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-13 16:30 | In 129 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 128 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-14 16:30 | In 38 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 37 days | ||
| General meeting for 2026 | 2026-05-14 10:00 | -- | ||
| First quarter earnings conference call for 2026 | 2026-05-13 16:30 | -- | ||
| First quarter earnings results for 2026 | 2026-05-13 | -- | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-23 16:30 | -- | ||
| Annual report for 2025 | 2026-03-23 | -- | ||
| Fourth quarter earnings results for 2025 | 2026-03-23 | -- |
Show
Entries
Bionano Genomics Inc Frequently Asked Questions
What is Bionano Genomics Inc(BNGOW)'s stock price today?
The current price of BNGOW is $0.00. The 52 week high of BNGOW is $4.47 and 52 week low is $0.00.
When is next earnings date of Bionano Genomics Inc(BNGOW)?
The next earnings date of Bionano Genomics Inc(BNGOW) is 2026-08-14 Est..
Does Bionano Genomics Inc(BNGOW) pay dividends? If so, how much?
Bionano Genomics Inc(BNGOW) does not pay dividend.
Guru Commentaries on NAS:BNGOW
No articles.
Press Release
Articles on Bionano Genomics Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers